image
Nuvectis Pharma, Inc. NVCT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.95
-13.6 %
$ 95.6 M
Market Cap
-4.27
P/E
BALANCE SHEET
19.2 M ASSETS
-5.98%
Growth Rates
1Year -5.98%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
6.98 M LIABILITIES
12.90%
Growth Rates
1Year 12.90%
3Years 787.23%
5Years 0.00%
7Years 0.00%
10Years 0.00%
12.2 M EQUITY
-14.19%
Growth Rates
1Year -14.19%
3Years 969.14%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Nuvectis Pharma, Inc.
image
Current Assets 19.2 M
Cash & Short-Term Investments 19.1 M
Receivables 0
Other Current Assets 59 K
Non-Current Assets 0
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 0
Current Liabilities 6.98 M
Accounts Payable 2.77 M
Short-Term Debt 0
Other Current Liabilities 4.21 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 19.1 20.0 5.7 0
Short Term Investments 0 0 0 0
Receivables 0 0 0 0
Inventory 0 0 0 0
Other Current Assets 59 K 0.4 91 K 0
Total Current Assets 19.2 20.4 5.8 0
PP&E 0 0 0 0
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0 0 0
Other Long Term Assets 0 0 0.8 0
Other Assets 0 0 0 0
Total Assets 19.2 20.4 6.7 0
LIABILITIES
Accounts Payable 2.8 2.9 1.1 10 K
Short Term Debt 0 0 0 0
Other Current Liabilities 4.2 3.3 1.4 0
Total Current Liabilities 7.0 6.2 2.4 10 K
Long Term Debt 0 0 0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 0 0 0 0
Total Liabilities 7.0 6.2 17.7 10 K
EQUITY
Common Stock 0 14 752.4 0 0
Retained Earnings (54.2) (32.0) (12.9) 10 K
Other Accumulative Comprehensive Income/Loss 0 (14 752.4) 0 0
Total Equity 12.2 14.2 (11.0) 10 K
Total Liabilities and Equity 19.2 20.4 6.7 0
SHARES OUTSTANDING
Common Shares Outstanding 15.6 12.7 12.7 12.7